Skip to main content
. 2019 Dec 5;2019:3519093. doi: 10.1155/2019/3519093

Table 2.

Distribution of patients by types of medications used and distribution of patients by clinical process indicator.

Variable Values Frequency Percentage BRFSS target Z-score p value
Distribution of patients by clinical process indicator (N = 643)            
Referral to dietitians Yes 256 39.9      
No 386 60.1      
Diet counseling Yes 401 37.6      
No 242 62.4      
Exercise counseling Yes 400 62.2      
No 243 37.8      
Foot examined Yes 576 89.6 74.8 5.05 <0.0001
No 67 10.4      
Eye examination referral Seen 465 72.3 58.7 5.93 <0.0001
Ordered not seen 96 14.9      
Not ordered 82 12.8      
HbA1c checked <2/year 323 50.3 71.1 −7.47 <0.0001
=>2/year 305 47.4      
Never 15 2.3      
Lipid checked Yes 595 92.8 58.3 15.14 <0.0001
No 46 7.2      
UCR checked Yes 520 80.9 37.0 30.50 <0.0001
No 123 19.1      
Influenza vaccine Given 263 40.9 80.0 −12.47 <0.0001
Ordered-not given 66 10.3      
Not ordered 314 48.8      
Pneumococcal vaccine Given 282 43.9 60.0 −6.86 <0.0001
Ordered-not given 27 4.2      
Not ordered 334 51.9      
Hepatitis B vaccine Given 48 7.5      
Ordered-not given 31 4.8      
Not ordered 564 87.7      
BP measurement Yes 627 97.5      
No 16 2.5      
BMI documented Yes 621 96.6      
No 22 3.4      
Depression Depressed 10 1.6      
Not depressed 143 22.2      
Not documented 490 76.2      
Distribution of patients by types of medications used (N = 643)            
Number of medications 0 9 1.4      
1 145 22.5      
2 157 24.4      
3 228 35.5      
4 92 14.6      
5 10 1.6      
Metformin Yes 578 89.9      
No 65 10.1      
DDP-4 inhibitors Yes 393 61.1      
No 250 38.9      
Sulfonylurea Yes 317 49.3      
No 326 50.7      
Insulin Yes 179 27.8      
No 464 72.2      
Thiazolidinedione Yes 65 10.1      
No 578 89.9      
GLP-1 agonists Yes 15 2.3      
No 628 97.7      
SGLT-2 inhibitors Yes 12 1.9      
No 630 98.1      
Meglitinides Yes 5 0.8      
No 638 99.2      
Aspirin Yes 230 35.8      
No 413 64.2      
Statin Yes 509 79.2      
No 134 20.8      
Vitamin D Yes 442 68.7      
No 201 31.3      
Antihypertensive ACE/ARBS 435 67.7      
Others 38 5.9      
No 170 26.4      

DDP-4 inhibitors: inhibitors of dipeptidyl peptidase 4; GLP-1: glucagon-like peptide-1 receptor; SGLT-2: sodium-glucose cotransporter-2; ACE/ARBs: angiotensin-converting enzyme/angiotensin receptor blockers; UCR: urinary creatinine ratio; BP: blood pressure; BMI: body mass index.